Earnings Scheduled For April 2, 2024
Portfolio Pulse from Benzinga Insights
Earnings reports for April 2, 2024, include a mix of expected profits and losses across various sectors. Notable companies like Paychex and Cal-Maine Foods anticipate earnings, while others like Allego and AIM ImmunoTech project losses. This diverse set of earnings could indicate sector-specific movements in the market.

April 02, 2024 | 10:25 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cal-Maine Foods projects strong Q4 earnings at $2.46 per share on $692.35 million revenue, indicating robust performance.
Strong earnings and revenue projections for Cal-Maine Foods suggest a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Paychex is expected to report strong Q4 earnings at $1.37 per share on $1.46 billion revenue, indicating positive momentum.
Strong earnings and revenue projections suggest positive short-term stock price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Dave & Buster's is likely to report strong Q4 earnings at $1.10 per share on $602.61 million revenue, potentially boosting investor confidence.
Projected strong earnings and revenue for Dave & Buster's indicate a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Gryphon Digital Mining's upcoming Q4 earnings report is anticipated by investors, focusing on its performance in the digital mining sector.
Without specific earnings projections, the impact remains neutral, but the digital mining sector's performance is of moderate interest.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Ocugen is set to report its Q4 earnings, with investor focus on its performance.
Without specific earnings projections, the impact is neutral, but relevance and importance are moderate due to investor interest in biotech.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEGATIVE IMPACT
Abivax is likely to report a significant Q4 loss at $2.14 per share, which could concern investors.
A significant projected loss could lead to negative investor sentiment, potentially lowering the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
AIM ImmunoTech expects a Q4 loss at $0.15 per share on minimal revenue, potentially impacting investor confidence.
Expected losses with minimal revenue could negatively affect stock price due to poor financial performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Allego projects a Q4 loss at $0.04 per share with revenue of $83.79 million, potentially affecting investor sentiment.
Projected losses could lead to negative short-term sentiment, impacting stock price negatively.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Vicinity Motor expects a Q4 loss at $0.06 per share on $12.62 million revenue, potentially impacting its stock negatively.
Expected quarterly loss could lead to negative sentiment among investors, potentially affecting the stock price adversely.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70